Skip to main content

Table 3 Enriched pathways of subtype 1 and subtype 2.

From: Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer

Enriched pathway in Subtype 2 (poor-prognosis) Enriched pathway in Subtype 1 (good-prognosis)
HSA03010_RIBOSOME HSA04080_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION
HSA00190_OXIDATIVE_PHOSPHORYLATION HSA04060_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
HSA04520_ADHERENS_JUNCTION HSA04742_TASTE_TRANSDUCTION (Sensory system)
HSA04510_FOCAL_ADHESION HSA04020_CALCIUM_SIGNALING_PATHWAY
HSA03050_PROTEASOME HSA04640_HEMATOPOIETIC_CELL_LINEAGE (Immune system)
HSA05212_PANCREATIC_CANCER HSA00140_C21_STEROID_HORMONE_METABOLISM
HSA04120_UBIQUITIN_MEDIATED_PROTEOLYSIS HSA00940_PHENYLPROPANOID_BIOSYNTHESIS
HSA05211_RENAL_CELL_CARCINOMA HSA01430_CELL_COMMUNICATION
HSA05220_CHRONIC_MYELOID_LEUKEMIA HSA00430_TAURINE_AND_HYPOTAURINE_METABOLISM